An intact mass match is necessary but not always sufficient for peptide identity. Several sequence errors, positional isomers and modification-site changes can share the same nominal or exact mass. Peptide sequence confirmation by LC-MS/MS adds fragment-level evidence, but the report is only as strong as its coverage, assignment rules and raw spectra.
Understand what intact mass leaves unresolved
Leucine and isoleucine are isobaric under routine MS. Some substitutions or rearrangements preserve composition. Deamidation can be confused with isotope selection or nearby interferences if resolution is inadequate. Disulfide pairing and modification position require more than a deconvoluted molecular weight.
Begin by checking the theoretical monoisotopic mass, terminal groups, salt-independent peptide ion and every modification. The observed precursor should show credible charge states and isotope envelopes, not just a software-generated number.
Fragmentation coverage matters more than a score
Collision-induced or higher-energy fragmentation commonly produces b- and y-type ions, while electron-based methods may be helpful for labile modifications or highly charged precursors. No method guarantees complete coverage. Proline, acidic regions, charge localization and modifications influence cleavage.
Ask for an annotated spectrum and a sequence-coverage map showing which peptide bonds are supported. A high database score can coexist with an unconfirmed terminal region or modification site. The report should distinguish directly localized features from assumptions based on precursor mass.
Short peptides and long peptides need different plans
A short peptide may generate too few unique fragments for confident discrimination. A long peptide may produce complicated charge states and incomplete central coverage. Enzymatic digestion can create manageable mapping peptides, but the protease and cleavage sites must suit the sequence.
For synthetic peptides, consider complementary enzymes or direct top-down fragmentation. The digestion blank and enzyme autolysis peaks should be controlled. Recovery must also be checked when a hydrophobic mapping fragment can adsorb or precipitate.
Disulfides require targeted mapping
Reduced analysis confirms cysteine-containing chains but loses the original connectivity. Non-reduced digestion followed by LC-MS/MS can support disulfide pairing when linked fragments are detected and correctly assigned. Scrambled isomers may be difficult to resolve and can require optimized digestion and chromatography.
State whether the supplier has confirmed the intended disulfide map or merely confirmed the correct number of oxidations. Those claims are not equivalent.
Modified peptides need localization evidence
Phosphorylation, glycosylation, lipidation, PEG linkers and fluorescent labels can fragment, suppress ionization or shift retention. Use fragmentation chemistry that preserves informative ions where possible. A mass shift on the precursor does not prove the modification sits on the specified residue.
Reference spectra or synthetic fragments can strengthen difficult assignments. Where MS cannot distinguish an isomer, say so and add an orthogonal method rather than forcing certainty.
Raw-data review checklist
- Precursor mass error, isotope selection and charge state.
- Fragment mass tolerance and assignment rules.
- Annotated product-ion spectra with signal-to-noise context.
- Sequence coverage and modification-site probability.
- Blank, carryover and coeluting impurity checks.
- Instrument, method version, software and analyst review.
Does LC-MS/MS prove the full sequence? It can provide strong confirmation when informative fragments cover the necessary bonds and sites. It may not distinguish leucine from isoleucine or resolve every disulfide or stereochemical question. The certificate should state those boundaries.
For supplier qualification, request sequence-confirmation data on the shipped batch or a scientifically justified representative lot. Keep the raw file available for independent review. A decorative spectrum inserted into a COA without precursor, fragments and method details is not sequence evidence.